Biomanufacturing

Pharma CEO On Opioids, Medication Prices And Overregulation

Anthony Tabasso, CEO of KVK Tech, talks with Chief Executive about the challenges in manufacturing a controlled substance, a highly-regulated industry, and manufacturing generic medications with lower price pressure.

Could Human Organs And Tissues Be The Next Frontier Of Manufacturing?

As 3D printing technologies and new materials open the doors for increasingly complex products, we’re on the verge of manufacturing life-saving products that could alter the course of history.

Dept. of Commerce Funds New Organization to Advance the Biopharma Industry

The U.S. Department of Commerce has awarded $70 million in funding to the new National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). It is the eleventh institute in the Manufacturing USA network and the first with a focus area proposed by industry and funded by the Department of Commerce.

Genomic Vision: How One CEO Realized His DNA Dream

How Aaron Bensimon’s experiments with the elasticity of DNA molecules evolved into a thriving biotech firm.
- Advertisement -
- Advertisement -

FEATURED CONTENT

New Poll: CEOs Find Challenges In Using Customer Data To Drive Innovation

Ability to harness and sort through data for meaningful insights remains a hurdle, many say. “The key is...finding what is actually relevant.”

SUBSCRIBE TO CHIEF EXECUTIVE

Sign Up to Receive Chief Executive Magazine

Chief Executive’s publications are designed to help CEOs do their jobs better and run their businesses more effectively. Subscribe here.

CEO CONFIDENCE INDEX

In Poll, Majority of CEOs Say Hybrid Work Is Here to Stay for 2022. Full Virtual? Not so Much

Almost all the CEOs we surveyed in May say they will work in at least partially hybrid mode for the rest of the year—versus just 7 percent who said they'd be fully remote.